Imaging test of lymph vessels using a new tracer
Part of Immune system & allergy clinical trials.
This early-stage study tests a new imaging method using a radioactive tracer to visualize lymph vessels in the belly and chest. Researchers want to understand how this imaging works in healthy people and in patients with suspected blockages in lymph vessels.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You must be 18 years or older
- You must be able to lie still in a PET/CT scanner (a tunnel-shaped imaging machine) without feeling claustrophobic
- You cannot be pregnant or breastfeeding
- You cannot have participated in other radiation studies in the past year
- You must be able to swallow pills and not be allergic to Ensure Plus (a nutritional drink)
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This early (Phase 1) study tests how a special scan works in people with relapsed or hard-to-treat leukemia types. The scan uses a tracer called 18F FLT, and the study looks to see if it can be done safely (without sedation) and how it relates to treatment.
This Phase 1 study tests a new PET/CT imaging tracer to see how well it can detect breast cancer spots in the body. It may help doctors learn where breast cancer is and how imaging could work better in the future.
This study uses a special PET/CT scan with a new tracer to see how TB infection looks in the lungs. It may help doctors better understand and treat TB.
This study uses a special scan (molecular imaging) to see how well antibody-drug conjugates (ADCs) work in people with breast cancer. It may help doctors choose the right treatment for you.
This early-phase study uses PET/CT scans to see how well a new radioactive tracer (a tiny dose of a special material) highlights solid tumors in the body. It may help researchers learn whether this tracer can better find and track tumor spots seen on standard scans.
This trial uses a new radioactive tracer that attaches to a protein found on many solid tumors, allowing doctors to see tumors on a PET scan. It may help improve how tumors are detected and monitored.
Hear when a new Lymphatic Obstruction trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.